Article
29 Oct 2020
Herbalife Agrees To Pay $123 Million To Settle Charges Related To 10-Year Bribery Scheme In China
AUTHORS CONTENT
Article
29 Nov 2019
DOJ Updates FCPA Corporate Enforcement Policy
Article
12 Feb 2019
World Bank Group Debars Brazil-Based Odebrecht Subsidiary Amid Allegations Of Fraudulent And Collusive Practices
Article
18 Jun 2018
FDA Issues Final Guidance Documents Relating To Medical Product Manufacturer Communications
Article
12 Mar 2018
Sanctions Enforcement – Recent Trends
Article
28 Dec 2017
Tax Reform: Deductibility Of Government Payments Materially Limited
Article
12 Oct 2017
Shanghai Tightens Industry Interactions With HCPs
Article
19 Sep 2017
CFIUS Continues To Present An Obstacle To Chinese Acquisitions
Article
26 Jun 2017
MedPAC Takes Anti-POD Stance In Report To Congress, Echoing An Increasingly Uniform Consensus
Article
15 May 2017
Managing Sanctions And Export Control Risks In The Health Care Industry
Article
03 May 2017
South Korea Fines Prominent Pharmaceutical Manufacturer in Latest Anti-Corruption Enforcement Efforts
Article
31 Mar 2017
A Judicial Reinterpretation of the Brazilian Constitution's Right to Health Care
Article
02 Feb 2017
FDA Issues Three Key Documents Relating To Medical Product Manufacturer Communications
Article
21 Dec 2016
Update On The Anti-Corruption Landscape In Mexico
Article
15 Nov 2016
FDA Holds Public Hearing On Manufacturer Communication Of Scientific And Medical Information
Article
15 Nov 2016
Podcast: FDA Holds Public Hearing On Manufacturer Communication Of Scientific And Medical Information
Article
20 Oct 2016
European Health Care Compliance Challenges (And Solutions)
Article
30 Sep 2016
Donations And Grants In China: Compliance Controls Beyond T&E
Article
07 Sep 2016
FDA Announces Public Hearing On Manufacturer Communications Regarding Off-Label Uses
Article
23 Jun 2016
Supreme Court Endorses Implied Certification Theory Under False Claims Act —"At Least In Some Circumstances"